A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS. Elevance Health and its direct and indirect subsidiaries, referred to throughout this document as “we,” “us,” “our,” the “Company” or “Elevance Health,” is a leading health company bringing together the concepts of elevate and advance. We are focused on enhancing well-being and advancing health outcomes by delivering integrated, whole health solutions across the care journey. We support consumers throughout their full health journeys with medical, pharmacy, and behavioral health services designed to address their whole health needs. Through this comprehensive approach, we aim to improve the health of the people and communities we serve. We advance our mission by collaborating with care providers and community organizations, fostering innovation that supports growth and equal opportunity for health access, and cultivating a high-performance culture.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 199.1B | 199.1B | 177.0B | 171.3B | 156.6B | 138.6B |
| Net Income | 5.7B | 5.7B | 6.0B | 6.0B | 5.9B | 6.1B |
| EPS | $25.21 | $25.21 | $25.68 | $25.22 | $24.28 | $24.73 |
| Free Cash Flow | 3.2B | 3.2B | 4.6B | 6.8B | 7.2B | 7.3B |
| ROIC | 9.1% | 7.8% | 8.5% | 9.6% | 10.1% | 10.7% |
| Gross Margin | 14.9% | 14.9% | 16.8% | 17.3% | 17.2% | 18.1% |
| Debt/Equity | 0.73 | 0.73 | 0.76 | 0.64 | 0.67 | 0.64 |
| Dividends/Share | $6.81 | $6.81 | $6.48 | $5.92 | $5.12 | $4.52 |
| Operating Income | 7.2B | 7.2B | 7.9B | 8.5B | 8.5B | 7.5B |
| Operating Margin | 3.6% | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% |
| ROE | 12.9% | 13.3% | 14.5% | 15.2% | 16.3% | 16.9% |
| Shares Outstanding | 225M | 225M | 233M | 237M | 243M | 247M |
Elevance Health, Inc. passes 6 of 9 quality checks, suggesting mixed fundamentals.
Elevance Health, Inc. trades at 12.5x trailing earnings, compared to its 15-year median P/E of 15.8x, suggesting it is currently Cheap relative to its historical range. On a free-cash-flow basis, the stock trades at 22.0x vs a median of 16.0x. The company's 5-year average ROIC is 9.3% with a gross margin of 16.9%. Total shareholder yield (dividends + buybacks) is 5.8%. At current prices, the estimated annualized return to fair value is -2.1%.
Elevance Health, Inc. (ELV) has a current P/E ratio of 12.5, compared to its historical median P/E of 15.8. The stock is currently considered Cheap based on its historical valuation range.
Elevance Health, Inc. (ELV) has a 5-year average return on invested capital (ROIC) of 9.3%. This is below average and may indicate limited pricing power.
Elevance Health, Inc. (ELV) has a market capitalization of $71.0B. It is classified as a large-cap stock.
Yes, Elevance Health, Inc. (ELV) pays a dividend with a trailing twelve-month yield of 2.15%. The company also returns capital through share buybacks, with a buyback yield of 3.67%.
Based on historical P/E analysis, Elevance Health, Inc. (ELV) appears cheap. The current P/E of 12.5 is 21% below its historical median of 15.8. The estimated fair value CAGR (P/E method) is 9.1%.
Elevance Health, Inc. (ELV) operates in the Hospital & Medical Service Plans industry, within the Financials sector.
Elevance Health, Inc. (ELV) reported annual revenue of $199.1 billion in its most recent fiscal year, based on SEC EDGAR filings.
Elevance Health, Inc. (ELV) has a net profit margin of 2.8%. This is a modest margin.
Elevance Health, Inc. (ELV) generated $3.2 billion in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Elevance Health, Inc. (ELV) has a debt-to-equity ratio of 0.73. This indicates moderate leverage.
Elevance Health, Inc. (ELV) reported earnings per share (EPS) of $25.21 in its most recent fiscal year.
Elevance Health, Inc. (ELV) has a return on equity (ROE) of 13.3%. This indicates moderate shareholder returns.
Elevance Health, Inc. (ELV) has a 5-year average gross margin of 16.9%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 19 years of financial data for Elevance Health, Inc. (ELV), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Elevance Health, Inc. (ELV) has a book value per share of $195.38, based on its most recent annual SEC filing.